Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
agitation
aluminum
Alzheimer's disease
Alzheimer's disease, age of onset
Alzheimer's disease, diagnosis of
Alzheimer's disease, familial
Alzheimer's disease, pathogenesis
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
amnesia
amyloid
amyloid beta protein
amyloid imaging
amyloid plaques
anti-amyloid therapy
anticholinesterase
anticonvulsants
apolipoprotein E
APP
APP gene
apraxia
apraxia, constructional
behavioral disorder
biologic markers
CAT scan, emission, abnormal
chromosomal abnormality
chromosome 9
cigarette smoking
cost
dementia
differential diagnosis
donepezil
dysnomia
echolalia
electromagnetic fields
executive dysfunction
familial
gene
gene mutation
genetic neurologic disorders
memory, impairment of
mild cognitive impairment
Mini Mental Status Examination
mitochondrial disease
molecular genetics
mongolism
neurofibrillary degeneration
neurologic disease, diagnoses of
neuropathology
neuroprotective agents
occupational neurologic disorders
paranoia
Parkinson disease
Parkinson disease, etiology of
personality change
Pittsburgh Compound B
presenilin-1 gene
presenilin-2 gene
prevention of neurologic disorders
review article
risk factors
senile plaques
single photon emission computed tomography
tau protein
tauopathy
treatment of neurologic disorder
TREM2 variants
ubiquilin 1
visuospatial disturbance
Showing articles 800 to 850 of 1068 << Previous Next >>

Failure to Detect Human T-Cell Leukemia Virus-Related Sequences in Multiple Sclerosis Blood
Arch Neurol 47:1064-1065, Chen,I.S.Y.,et al, 1990

No Evidence for Human T-Cell Leukemia Virus Type I or Human T-Cell Leukemia Virus Type II Infection in Patients with MS
Arch Neurol 47:1061-1063, Perl,A.,et al, 1990

Risk Factors for Multiple Sclerosis:Race or Place? Editorial
JNNP 53:821-823, 903, 906990., Compston,A., 1990

A Double-Blind, Controlled Trial of Intravenous Immunoglobulin in Patients with Chronic Fatigue Syndrome
Am J Med 89:561-568, 551-5531990., Lloyd,A.,et al, 1990

A Controlled Trial of Intravenous Immunoglobulin G in Chronic Fatigue Syndrome
Am J Med 89:554-560, 551-5531990., Peterson,P.K.,et al, 1990

What Causes Motoneuron Disease?
Editorial, Lancet 336:1033-10351990., , 1990

Progressive Aphasia:A Precursor of Global Dementia
Neurol 40:423-429, Green,J.,et al, 1990

Transmission and Age-At-Onset Patterns in Familial Alzheimer's Disease:Evidence for Heterogeneity
Neurol 40:395-403, Farrer,L.A.,et al, 1990

Psychotic Symptoms in Alzheimer's Disease
Editorial, Lancet 2:1193-11941989., , 1989

Geographical Relation Between Alzheimer's Disease and Aluminium in Drinking Water
Lancet 1:59-62, Martyn,C.N.,et al, 1989

Severely Threatening Events and Marked Life Difficulties Preceding Onset or Exacerbation of MS
JNNP 52:8-13, Grant,I.,et al, 1989

Predisposing Locus for Alzheimer's Disease on Chromosome 21
Lancet 1:352-355, Goate,A.M.,et al, 1989

Diagnosis of Dementia:Clinicopathologic Correlations
Neurol 39:76-79, Boller,F.,et al, 1989

Did Leonardo Describe Parkinson's Disease?
NEJM 320:593, Calne,D.B.,et al, 1989

Progressive Aphasia without Dementia:Further Documentation
Ann Neurol 25:411-413, Sapin,L.R.,et al, 1989

Apraxia in Alzheimer's Disease
Neurol 39:664-668, Rapcsak,S.Z.,et al, 1989

Tetrahydroaminoacridine (THA) in Alzheimer's Disease, Not Ready for Routine Use
BMJ 298:845-846, Graham,T.R.&Lewis,C.T., 1989

Clonidine Treatment of Alzheimer's Disease
Arch Neurol 46:376-378, Mohr,E.,et al, 1989

Reliability of Clinical Criteria for the Diagnosis of Dementia, A Longitudinal Multicenter Study
Arch Neurol 46:646-648, Forette,F.,et al, 1989

Multicenter Trial of Naloxone in Alzheimer's Disease
Ann Neurol 25:404-406, Henderson,V.W.,et al, 1989

A Pilot Study of Haloperidol Treatment of Psychosis and Behavioral Disturbance in Alzheimer's Disease
Arch Neurol 46:854-857, Devanand,D.P.,et al, 1989

Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
NEJM 320:1446-1452, 1484-14861989., Rumble,B.,et al, 1989

Relationship of Hearing Impairment to Dementia and Cognitive Dysfunction in Older Adults
JAMA 261:1916-1919, Uhlmann,R.F.,et al, 1989

Quantitation of Cerebral Atrophy in Preclinical and End-Stage Alzheimer's Disease
Ann Neurol 25:450-459, delaMonte,S.M., 1989

Rising Mortality From Motoneuron Disease in the USA, 1962-84
Lancet 1:710-712, Lilienfeld,D.E.,et al, 1989

Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease, A Role for Extranigral Factors?
Arch Neurol 46:651-657, Morris,J.C.,et al, 1989

Environmental Factors and Parkinson's Disease:A Case-Control Study in China
Neurol 39:660-664, Tanner,C.M.,et al, 1989

Current Theories on the Cause of Parkinson's Disease
JNNP Suppl (June) 52:13-17989., Langston,J.W., 1989

Induction of Parkinsonism by Intraventricular Bethanechol in a Patient with Alzheimer's Disease
Neurol 39:1265, Fox,J.H.,et al, 1989

Neuropathological Correlates of Leuko-araiosis
Arch Neurol 46:1124-1128, Janota,I.,et al, 1989

Prevalence of Alzheimer's Disease in a Community Population of Older Persons
JAMA 262:2551-2556, 2591-25921989., Evans,D.A.,et al, 1989

Gerstmann-Straussler-Scheinker Disease, II, Neurofibrillary Tangles & Plaques with PrP-amyloid in an Affected Family
Neurol 39:1453-1461, Ghetti,B.,et al, 1989

Effects of a Training Programme to Reduce Stress in Carers of Patients with Dementia
BMJ 299:1375-1379, Brodaty,H.&Gresham,M., 1989

Posterior Cortical Atrophy
Arch Neurol 45:789-793, Benson,D.F.,et al, 1988

Why Are Alzheimer Patients Thin?
Age & Ageing 17:21-28988., Singh,S.,et al, 1988

Neurologic Fragments. I. Clinical Observations in Demented Patients
Neurol 38:1868-1873, Fisher,C.M., 1988

Immunocytochemistry of Neurofibrillary Tangles in Dementia Pugilistica and Alzheimer's Disease:Evidence for Common Genesis
Lancet 2:1456-1458, Roberts,G.W., 1988

Clinico-Pathologic Studies in Dementia:Nondemented Subjects with Pathologically Confirmed Alzheimer's Disease
Neurol 38:1682-1687, Crystal,H.,et al, 1988

Brain Amyloid and Alzheimer Disease
Ann Int Med 109:41-54, Vinters,H.V.,et al, 1988

Motor Vehicle Crashes in Dementia of the Alzheimer Type
Ann Neurol 24:782-786, Friedland,R.P.,et al, 1988

Who May Drive? Who May Not? Who Shall Decide?
Ann Neurol 24:787-788, Drachman,D.A., 1988

The Molecular Genetic Revolution, Its Impact on Clinical Neurology
Arch Neurol 45:1366-1376, Payne,C.S.&Roses,A.D., 1988

Long-Term Administration of Oral Physostigmine in Alzheimer's Disease
Neurol 38:1837-1841, Stern,Y.,et al, 1988

Aluminium, Chemical Physiology and Alzheimer's Disease
Lancet 2:1008-1010, Birchall,J.D.&Chappell,J.S., 1988

Familial Alzheimer's Disease with Myoclonus and'Spongy Change'
Arch Neurol 45:1097-1100, Duffy,P.,et al, 1988

Diagnosing Dementia:Do We Get It Right?
BMJ 297:894-896, Homer,A.C.,et al, 1988

Intraventricular Bethanechol Infusion for Alzheimer's Disease:Double-Blind & Escalating-Dose Trials
Neurol 38:219-222, 307-3081988., Penn,R.D.,et al, 1988

Early Alzheimer's Disease, Diagnostic Considerations
Arch Neurol 45:345-349, Morris,J.C.&Fulling,K., 1988

The NINCDS-ADRDA Work Group Criteria for the Clin Diag of Prob Alzheimer's Dis:A Clinicopath Study of 57 Cases
Neurol 38:359-364, Tierney,M.D.,et al, 1988

Clinical, Path, & Neurochem Changes in Dementia:Subgroup with Preserved Mental Status & Neocortical Plaques
Ann Neurol 23:138-144, Katzman,R.,et al, 1988



Showing articles 800 to 850 of 1068 << Previous Next >>